Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Pulmatrix, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 16 | 13 | −3 |
| Shares | 1.49M | 569.7K | −921.4K (−61.8%) |
| Value | $2.71M | $2.04M | −$677.0K (−25.0%) |
New holders (1)
Institutions that held Pulmatrix, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Abound Wealth Management | 1 | $4 | 0.00% |
Sold out (4)
Institutions that held Pulmatrix, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 30,628 | $141.0K |
| Parallax Volatility Advisers, L.P. | 904,896 | $22.0K |
| Bank of America Corp | 25 | $0 |
| Captrust Financial Advisors | 25 | $0 |